Skip to content

In the BioHarmony Drug Report Database

Voriconazole

Vfend, Voriconazole (voriconazole) is a small molecule pharmaceutical. Voriconazole was first approved as Vfend on 2002-03-19. It is used to treat aspergillosis, candidiasis, fusariosis, and mycoses in the USA. It has been approved in Europe to treat aspergillosis, bacterial infections and mycoses, candidiasis, and mycoses.
Trade Name Vfend
Common Name Voriconazole
Indication aspergillosis, bacterial infections and mycoses, candidiasis, fusariosis, mycoses
Drug Class Systemic antifungals (miconazole type)
Voriconazole
Get full access now